Christophe Boetsch

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 11

Top Topics

Induced Pluripotent Stem Cells

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Solange Peters, Eric Angevin, Teresa Alonso Gordoa, Kristoffer Staal Rohrberg, Ignacio Melero Bermejo, Begona Mellado, Jose-Luis Perez-Gracia, Josep Tabernero, Celine Adessi, Christophe Boetsch, Carl Watson, Joseph Dal Porto, David Dejardin, Christopher Del Nagro, Valeria Nicolini, Stefan Evers, Christiane Neumann, Barbara Leutgeb, Pavel Pisa, Eva Rossmann, José Saro, Pablo Umaña, Jehad Charo, Volker Teichgräber, Neeltje Steeghs
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Solange Peters, Eric Angevin, Teresa Alonso Gordoa, Kristoffer Staal Rohrberg, Ignacio Melero Bermejo, Begona Mellado, Jose-Luis Perez-Gracia, Josep Tabernero, Celine Adessi, Christophe Boetsch, Carl Watson, Joseph Dal Porto, David Dejardin, Christopher Del Nagro, Valeria Nicolini, Stefan Evers, Christiane Neumann, Barbara Leutgeb, Pavel Pisa, Eva Rossmann, José Saro, Pablo Umaña, Jehad Charo, Volker Teichgräber, Neeltje Steeghs
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Prathap Nagaraja Shastri, Nirav Shah, Martin Lechmann, Hardik Mody, Marc W Retter, Min Zhu, Tommy Li, Jun Wang, Naveed Shaik, Xirong Zheng, Meric Ovacik, Fei Hua, Vibha Jawa, Christophe Boetsch, Yanguang Cao, John Burke, Kaushik Datta, Kapil Gadkar, Vijay Upreti, Alison Betts
Industry Perspective on First-in-Human and Clinical Pharmacology Strategies to Support Clinical Development of T-Cell Engaging Bispecific Antibodies for Cancer Therapy. Clinical pharmacology and therapeutics (2024)
Neeltje Steeghs, Carlos Alberto Gomez Roca, Kristoffer Staal Rohrberg, Morten Mau Sorensen, Debbie G J Robbrecht, Josep Tabernero, Samreen Ahmed, Maria E Rodríguez-Ruiz, Caroline Ardeshir, Daniela Schmid, Nassim Sleiman, Carl Watson, Hanna Piper-Lepoutre, David Dejardin, Stefan Evers, Christophe Boetsch, Jehad Charo, Volker Teichgräber, Ignacio Melero Bermejo
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Sara Belli, Maria Amann, Lucy Hutchinson, Laurène Pousse, Afsaneh Abdolzade-Bavil, Nicole Justies, Bjoern Jacobsen, Corinne Ploix, Eleni Tselempi, Vinko Tosevski, Hans Koll, Gabriel Schnetzler, Christophe Boetsch, Estelle Marrer-Berger
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg-Depleting Antibody. Clinical pharmacology and therapeutics 116 (3) (2024)
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II study to determine the anti-tumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Neeltje Steeghs, Carlos Alberto Gomez Roca, Kristoffer Staal Rohrberg, Morten Mau Sorensen, Debbie G J Robbrecht, Josep Tabernero, Samreen Ahmed, Maria E Rodríguez-Ruiz, Caroline Ardeshir, Daniela Schmid, Nassim Sleiman, Carl Watson, Hanna Piper-Lepoutre, David Dejardin, Stefan Evers, Christophe Boetsch, Jehad Charo, Volker Teichgräber, Ignacio Melero Bermejo
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Neeltje Steeghs, Carlos Alberto Gomez Roca, Kristoffer Staal Rohrberg, Morten Mau Sorensen, Debbie G J Robbrecht, Josep Tabernero, Samreen Ahmed, Maria E Rodríguez-Ruiz, Caroline Ardeshir, Daniela Schmid, Nassim Sleiman, Carl Watson, Hanna Piper-Lepoutre, David Dejardin, Stefan Evers, Christophe Boetsch, Jehad Charo, Volker Teichgräber, Ignacio Melero Bermejo
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Sara Belli, Maria Amann, Lucy Hutchinson, Laurène Pousse, Afsaneh Abdolzade-Bavil, Nicole Justies, Bjoern Jacobsen, Corinne Ploix, Eleni Tselempi, Vinko Tosevski, Hans Koll, Gabriel Schnetzler, Christophe Boetsch, Estelle Marrer-Berger
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg-Depleting Antibody. Clinical pharmacology and therapeutics (2024)
Neeltje Steeghs, Carlos Alberto Gomez Roca, Kristoffer Staal Rohrberg, Morten Mau Sorensen, Debbie G J Robbrecht, Josep Tabernero, Samreen Ahmed, Maria E Rodríguez-Ruiz, Caroline Ardeshir, Daniela Schmid, Nassim Sleiman, Carl Watson, Hanna Piper-Lepoutre, David Dejardin, Stefan Evers, Christophe Boetsch, Jehad Charo, Volker Teichgräber, Ignacio Melero Bermejo
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)